Dicerna Announces Positive Updated Data From Phase 1 Trial Of RG6346 For Treatment Of Chronic Hepatitis B Virus (HBV) Infection At AASLD's The Liver Meeting® Digital Experience™ 2020

Media coverage

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial Of RG6346 For Treatment Of Chronic Hepatitis B Virus (HBV) Infection At AASLD's The Liver Meeting® Digital Experience™ 2020
  Media name/outlet	TheStreet.com
  Country/Territory	United States
  Date	16/11/20
  URL	https://www.thestreet.com/press-releases/dicerna-announces-positive-updated-data-from-phase-1-trial-of-rg6346-for-treatment-of-chronic-hepatitis-b-virus-hbv-infection-at-aasld-s-the-liver-meeting-reg-digital-experience-trade-2020-15490037
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD's The Liver Meeting® Digital Experience(TM) 2020; - Data Presentations Show Treatment With Up to Four Monthly Doses of
  Media name/outlet	Business Wire
  Country/Territory	United States
  Date	16/11/20
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020
  Media name/outlet	Business Wire
  Country/Territory	United States
  Date	16/11/20
  URL	https://www.businesswire.com/news/home/20201116005423/en
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020
  Media name/outlet	Morningstar.com
  Country/Territory	United States
  Date	16/11/20
  URL	https://www.morningstar.com/news/business-wire/20201116005423/dicerna-announces-positive-updated-data-from-phase-1-trial-of-rg6346-for-treatment-of-chronic-hepatitis-b-virus-hbv-infection-at-aaslds-the-liver-meeting-digital-experience-2020
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020
  Media name/outlet	StocksNewsFeed.com
  Country/Territory	United States
  Date	16/11/20
  URL	https://stocksnewsfeed.com/businesswire/dicerna-announces-positive-updated-data-from-phase-1-trial-of-rg6346-for-treatment-of-chronic-hepatitis-b-virus-hbv-infection-at-aaslds-the-liver-meeting-digital-experience-2/
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020
  Media name/outlet	Yahoo! Finance
  Country/Territory	United States
  Date	16/11/20
  URL	https://finance.yahoo.com/news/dicerna-announces-positive-updated-data-123100270.html
  Persons	John M Young

• Title	DICERNA PHARMACEUTICALS : Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD's The Liver Meeting® Digital Experience™ 2020
  Media name/outlet	MarketScreener.com
  Country/Territory	United States
  Date	16/11/20
  URL	https://www.marketscreener.com/quote/stock/DICERNA-PHARMACEUTICALS-15657740/news/Dicerna-Pharmaceuticals-Announces-Positive-Updated-Data-From-Phase-1-Trial-of-RG6346-for-Treatment-31791648/
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Ph...
  Media name/outlet	ADVFN Deutschland
  Country/Territory	Germany
  Date	16/11/20
  URL	de.advfn.com/p.php?pid=nmona&article=83690915
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD ’s The Liver Meeting ® Digital Experience ™ 2020
  Media name/outlet	Stockwatch
  Country/Territory	Canada
  Date	16/11/20
  URL	www.stockwatch.com/News/Item?bid=U-b20201116005423-U:DRNA-20201116&symbol=DRNA&region=U
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020
  Media name/outlet	Crwe World
  Country/Territory	United States
  Date	16/11/20
  URL	crweworld.com/article/news-provided-by-business-wire/1776680/dicerna-announces-positive-updated-data-from-phase-1-trial-of-rg6346-for-treatment-of-chronic-hepatitis-b-virus-hbv-infection-at-aaslds-the-liver-meeting-digital-experience-2020
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020
  Media name/outlet	Market Newsdesk
  Country/Territory	United States
  Date	16/11/20
  URL	www.marketnewsdesk.com/?p=381533
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020
  Media name/outlet	Digital Media Net
  Country/Territory	United States
  Date	16/11/20
  URL	dmnnewswire.digitalmedianet.com/2020/11/16/dicerna-announces-positive-updated-data-from-phase-1-trial-of-rg6346-for-treatment-of-chronic-hepatitis-b-virus-hbv-infection-at-aaslds-the-liver-meeting-digital-experience-2/?utm_source=rss&utm_medium=rss&utm_campaign=dicerna-announces-positive-updated-data-from-phase-1-trial-of-rg6346-for-treatment-of-chronic-hepatitis-b-virus-hbv-infection-at-aaslds-the-liver-meeting-digital-experience-2
  Persons	John M Young

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver M
  Media name/outlet	Acrofan
  Date	15/11/20
  URL	https://us.acrofan.com/detail.php?number=374397
  Persons	John M Young